Muscle wasting in myotonic dystrophies: a model of premature aging AJ Mateos-Aierdi, M Goicoechea, A Aiastui, R Fernández-Torrón, ... Frontiers in aging neuroscience 7, 125, 2015 | 119 | 2015 |
SOX9 Elevation Acts with Canonical WNT Signaling to Drive Gastric Cancer Progression JC Santos, E Carrasco-Garcia, M Garcia-Puga, P Aldaz, M Montes, ... Cancer research 76 (22), 6735-6746, 2016 | 116 | 2016 |
Paradoxical role of SOX2 in gastric cancer E Carrasco-Garcia, JC Santos, I Garcia, M Brianti, M García-Puga, ... American journal of cancer research 6 (4), 701, 2016 | 52 | 2016 |
Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation R Fernández-Torrón, M García-Puga, JI Emparanza, M Maneiro, ... Neurology 87 (12), 1250-1257, 2016 | 49 | 2016 |
Myotonic Dystrophy type 1 cells display impaired metabolism and mitochondrial dysfunction that are reversed by metformin M García-Puga, A Saenz-Antoñanzas, R Fernández-Torrón, ... Aging (Albany NY) 12 (7), 6260, 2020 | 39 | 2020 |
SOX9 promotes tumor progression through the axis BMI1-p21CIP P Aldaz, M Otaegi-Ugartemendia, A Saenz-Antonanzas, M Garcia-Puga, ... Scientific reports 10 (1), 357, 2020 | 39 | 2020 |
Towards precision medicine: linking genetic and cellular heterogeneity in gastric cancer E Carrasco-Garcia, M García-Puga, S Arevalo, A Matheu Therapeutic advances in medical oncology 10, 1758835918794628, 2018 | 20 | 2018 |
Targeting myotonic dystrophy type 1 with metformin M García-Puga, A Saenz-Antoñanzas, A Matheu, A López de Munain International journal of molecular sciences 23 (5), 2901, 2022 | 18 | 2022 |
Chaperone-mediated autophagy controls proteomic and transcriptomic pathways to maintain glioma stem cell activity J Auzmendi-Iriarte, M Otaegi-Ugartemendia, E Carrasco-Garcia, ... Cancer research 82 (7), 1283-1297, 2022 | 14 | 2022 |
Therapeutic relevance of SOX9 stem cell factor in gastric cancer E Carrasco-Garcia, M Álvarez-Satta, M García-Puga, ML Ribeiro, ... Expert Opinion on Therapeutic Targets 23 (2), 143-152, 2019 | 13 | 2019 |
Senescence plays a role in myotonic dystrophy type 1 M García-Puga, A Saenz-Antoñanzas, G Gerenu, A Arrieta-Legorburu, ... JCI insight 7 (19), 2022 | 8 | 2022 |
∆Np73 is capable of inducing apoptosis by co-ordinately activating several BH3-only proteins D Sánchez-Carrera, M García-Puga, L Yáñez, Í Romón, C Pipaón Bioscience Reports 35 (3), 2015 | 5 | 2015 |
Leukocyte telomere length in patients with myotonic dystrophy type I: a pilot study Y Wang, A Best, R Fernández‐Torrón, R Alsaggaf, M Garcia‐Puga, ... Annals of Clinical and Translational Neurology 7 (1), 126-131, 2020 | 4 | 2020 |
Biallelic variants in SNUPN cause a limb girdle muscular dystrophy with myofibrillar-like features P Iruzubieta, A Damborenea, M Ioghen, S Bajew, R Fernandez-Torrón, ... Brain, awae046, 2024 | 1 | 2024 |
Nuevas estrategias terapéuticas en la Distrofia Miotónica tipo 1 basadas en los mecanismos moleculares del envejecimiento y del cáncer M García Puga Universidad del País Vasco, 2021 | | 2021 |
Impact of Stem Cell Genes in Gastric Cancer E Carrasco-Garcia, M García-Puga, M Moreno, N Sampron, S Arevalo, ... Gastric Cancer, 2017 | | 2017 |
Impact of SOX Stem Cell Factors in Gastric Cancer E Carrasco-Garcia, J Carvalho-Santos, M García-Puga, N Sampron, ... | | 2016 |